Stay updated on Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.

Latest updates to the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov record for the Nintedanib and Pirfenidone IPF study is now displayed instead of an access error, with details about the completed Phase 4 trial and its results, participants, and locations.SummaryDifference53%

- Check16 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2. The page remains a 403 Forbidden error rather than showing the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces changes to NIH websites and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during the transition.SummaryDifference1%

- Check30 days agoChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study details. This indicates an access restriction rather than a content update to the study information.SummaryDifference17%

Stay in the know with updates to Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability PK of Nintedanib with Pirfenidone in IPF Clinical Trial page.